Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran

Abstract

Human leukocyte antigen (HLA) types were obtained from 79 Iranian patients with multiple sclerosis and compared with 100 controls. The prevalence of HLA-A24 (30.3% versus 18.0%), HLA-DR2 (43.0% versus 28.0%) and HLA-DR15 (36.7% versus 23.0%) were significantly increased in multiple sclerosis patients compared with controls. However age at onset, and disease status (relapsing-remitting or primary progressive) did not show an association with any particular HLA type.

Keywords

HLA multiple sclerosis Iran

Get full access to this article

View all access options for this article.

References

Acheson ED. (1977) Epidemiology of multiple sclerosis . Br Med Bull 33: 9-14 .

Oger J , Arnason BGW. (1980) HLA patterns in multiple sclerosis. In: Bauer H (ed). Progress in multiple sclerosis research. Springer-Verlag: Berlin , pp 460-464.

Kurdi A et al. (1977) Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and Northern Europeans . Lancet i: 1123-1125 .

Marrosu MG et al. (1992) HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1.0201 and DQB1.0302 alleles . Neurology 42: 883-886 .

Marrosu MG et al. (1998) DRB1-DQA1-DQB1 Loci and multiple sclerosis predisposition in the Sardinian population . Hum Mol Genet 7-8: 1235-1237 .

Ebers GC , Dyment DA. (1998) Genetics of multiple sclerosis . Semin Neurol 18: 295-299 .

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guide lines for research protocols . Ann Neurol 13: 227-231 .

Offenbacher H et al. (1993) Assessment of MRI criteria for a diagnosis of MS . Neurology 43: 905-909 .

Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

10.

Francis DA and the British & Dutch multiple sclerosis azathioprine trial group . (1988) Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine . J Neurol Neurosurg Psych 51: 412-415 .

11.

Walker H (ed). (1993) Technical manual, American Association of Blood Banks (AABB). 11th edn. pp 687-704.

12.

Nikbin B , Khosravi F , Kamgooyan M. (1986) The distribution of class I and class II HLA antigens in an Iranian population using the 3rd A.O.H.W.C. Antisera. In Aizawa M (ed). HLA in Asia & Oceania. Hokkaido University press: Sapporo , pp 552-555.

13.

Carra A et al. (1999) The association of HLA DR2 in caucasian multiple sclerosis patients in Buenos Aires, Argentina . Multiple Sclerosis 5: S30-S30 .

14.

Weatherby SJM et al. (1999) HLA DR15. Outcome and susceptibility in multiple sclerosis . Multiple Sclerosis 5: S32-S32 .

15.

Strenja-Linic I et al. (1999) HLA antigens of multiple sclerosis patients in Istria, Western Croatia . Multiple Sclerosis 5: S32-S32 .

16.

Pina MA et al. (1999) Study of HLA as a predisposing factor and its possible influence on the outcome of multiple sclerosis in the sanitary district of Calatayud, northern Spain . Neuroepidemiology 18: 203-209 .

17.

Shiralieva RK , Guseinova KA. (1998) Characteristic of histocompatibility antigens distribution in patients with multiple sclerosis . Klin Med Mosk 76: 19-20 .

18.

One T et al. (1998) Molecular analysis of HLA class I (Hla-A and B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type) . Tissue Antigens 52: 539-552 .

19.

Lotfi J et al. (1974) Histocompatibility antigens (HLA) in multiple sclerosis in Iran . J Neuro Neurosurg Psych 41: 699-701 .

20.

Saruhan-Direskeneli G et al. (1997) HLA-DR and -DQ associations with multiple sclerosis in Turkey . Hum Immunol 55: 59-65 .

21.

Fryze W et al. (1997) Class II HLA antigens in patients with multiple sclerosis from Warsaw and Gadansk regions . Neurol Neurochir Pol 31: 229-236 .